HomeAI · summaries
Storia in 4 fonti
Novo Nordisk bids $9bn for obesity drug maker Metsera in challenge to Pfizer
US biotech viewed as lucrative target partly because of its promising pipeline of weight-loss drugs
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
cnbc.com
Novo Nordisk hijacks Pfizer with bid for U.S. biotech Metsera
Denmark's Novo Nordisk said on Thursday it has made an unsolicited bid for U.S. drug maker Metsera, after Pfizer last week made an offer for the company.
- ·
ft.com
Novo Nordisk gatecrashes Pfizer deal with $9bn bid for Metsera
Pfizer had struck deal in September to buy obesity-focused biotech
